共 159 条
[1]
Nicolaides KH(2011)A model for a new pyramid of prenatal care based on the 11–13 weeks’ assessment Prenat Diagn 31 3-6
[2]
Snijders R(1998)UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10–14 weeks of gestation Lancet 352 343-346
[3]
Noble P(1992)Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy BMJ 304 867-869
[4]
Sebire N(2016)Development of prenatal screening—a historical overview Semin Perinatol 40 12-22
[5]
Nicolaides KH(1999)A screening program for trisomy 21 at 10–14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A Ultrasound Obstet Gynecol 13 231-237
[6]
Azar G(1999)Maternal age- and gestation-specific risk for trisomy 21 Ultrasound Obstet Gynecol 13 167-170
[7]
Byrne D(2008)First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics Ultrasound Obstet Gynecol 31 493-502
[8]
Cuckle H(2008)A mixture model of nuchal translucency thickness in screening for chromosomal defects Ultrasound Obstet Gynecol 31 376-383
[9]
Maymon R(2008)Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A Ultrasound Obstet Gynecol 31 618-624
[10]
Spencer K(2008)Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free-hCG and pregnancy-associated plasma protein-A Hum Reprod 23 1968-1975